CDMO Best Practices from Benches to Batches - How to Transition from Clinical to Commercial Readiness

Product

Information

What you need to seamlessly transition from clinical phases to commercial readiness. Three unique abilities your CDMO must have to complete your project within your timeline are capability, flexibility and availability. August Bioservices' Director of Customer Operations, Commercial Development, offers several insights as to why August Bioservices is rapidly moving from the best kept secret in the CDMO industry, to one of the fastest-growing and most sought-after partners in the sterile injectables space.
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
United States
Main Categories
Finished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
All Categories
InjectablesContract ManufacturingContract Manufacturing of Dosage Form Drugs
August Bioservices1519August Bioservices is a US-based, quality-driven CDMO that offers end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish cGMP manufacturing to clients of all sizes and stages, from pre-clinical to commercial, all under one roof. Focus Areas: sterile injectables, high-complexity formulations, poorly soluble & highly viscous compounds, uncommon container sizes & fill volumes Expanded capacity with multiple new fill/finish lines!

Log in

See all the content and easy-to-use features by logging in or registering!